Health AI Register Logo
ProductsPlatformsCompaniesNewsContact
ProductsArteraAI Breast Cancer Test

Public source

Reviewed 21 Jul 2026

Completeness Fair (39%)

ArteraAI Breast Cancer Test

ArteraAI

The ArteraAI Breast Cancer Test is designed to deliver prognostic and predictive insights for patients with early-stage HR+ breast cancer to help personalize breast cancer treatment decisions.

Supported by 1 paper

General Information

Product name

ArteraAI Breast Cancer Test

Company

Modality

Histopathology

Main task

Prognosis (Risk stratification)

Subspeciality

Breast pathology

Organ/Specimen source

Not specified

Disease targeted

Breast cancer

Specimen type

Biopsy

Staining

H&E

Stain subtype

Not specified

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Regulation (IVDR)

Class:

Class C

Not verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

Not specified

Scanner Models Certified for Use (CE-IVD)

Not specified

Other certifications

Not specified

Evidence & Research

Technical Specifications

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

External service

Trigger for analysis

Not specified

Processing time

Not specified

Population

The ArteraAI Breast Cancer Test is intended to assist clinicians with risk-based decisions in female patients with HR+/HER2- early stage invasive breast cancer within recommended clinical guidelines. The test is intended to be ordered after tumor resection for patients who have not received neoadjuvant therapy prior to surgery.

Viewer systems

Not specified

Market Presence

On market since

Not specified

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Pay-per-use

Based on

Not specified

Source: Public | First published: Apr 21, 2026 | Last updated: Jul 21, 2026